| 摘要 |
This invention relates to a method of detecting an angiocidin fragment and/or aggregate and/or an epitope therein in the blood, blood plasma, serum, another bodily fluid, a biopsy or other tissue, of a mammal, especially a human, as a means of detecting, diagnosing and/or following a cancer. It also relates to particular fragments of angiocidin. |
